发明名称 |
TREATMENT OF TAUOPATHIES BY PASSIVE IMMUNIZATION TARGETING THE N-TERMINAL PROJECTION DOMAIN OF TAU |
摘要 |
A method of treating tau pathologies, such as Alzheimer's disease, involving the administration of antibodies specific to the amino terminal region of human tau (amino acid residues 6-18 or 184-195) to provide passive immunization. The administration of such antibodies can reduce total tau levels, decrease tau hyperphosphorylation, and improve reference memory. Passive immunization with antibodies targeting the N-terminal projection domain of tau reduces both total and hyperphosphorylated tau was found effective in aged 3×Tg-AD mice, a generally accepted mouse model of Alzheimer's disease and frontotemporal dementia in humans. |
申请公布号 |
US2016102138(A1) |
申请公布日期 |
2016.04.14 |
申请号 |
US201514880425 |
申请日期 |
2015.10.12 |
申请人 |
The Research Foundation for Mental Hygiene, Inc. |
发明人 |
Iqbal Khalid;Grundke-Iqbal Inge |
分类号 |
C07K16/18 |
主分类号 |
C07K16/18 |
代理机构 |
|
代理人 |
|
主权项 |
1. A pharmaceutical composition for treating a subject having a tauopathy, comprising a non-naturally occurring antibody that binds to a portion of the N-terminal projection domain of tau. |
地址 |
Menands NY US |